There are diseases so rare that those affected often wait years for a diagnosis. For many of them, there is only one treatment option: plasma‑based therapies.
The TV documentary “Welt der Wunder” shows how donated blood plasma is turned into life‑saving therapies—and why these treatments are indispensable for many patients, and in some cases, even lifesaving.
The report first aired on 22 June on “Welt der Wunder” TV and is available on the “Welt der Wunder” YouTube channel (in German).
The nearly eight‑minute documentary centers on Thomas’s story. He lives with a genetic deficiency of alpha‑1 antitrypsin—his body cannot produce this essential protein on its own. Only through regular treatment with plasma‑based therapies can he compensate for this deficiency and manage his daily life. His story makes one thing clear: for those affected, these therapies are not optional—they are essential for survival.
The documentary also illustrates why blood plasma is such a unique resource. Unlike many other active ingredients, it cannot be produced artificially. The proteins, antibodies, and clotting factors it contains come exclusively from healthy donors. Their willingness to donate forms the foundation of therapies on which thousands of patients depend.
A central challenge is the growing demand for plasma. More patients are being diagnosed, and treatment options are expanding—yet in many places, supply is not keeping pace. The documentary highlights just how crucial every single donation is.
Another key focus is the donation and manufacturing process. Donated plasma is carefully tested and processed under strictly controlled conditions. Every step follows clearly defined procedures and the highest quality standards—from collection to the finished batch. The process is complex and time‑consuming, with each therapy taking nine to twelve months to produce.
“Welt der Wunder” succeeds in making the complex interdependencies behind plasma‑based therapies both understandable and tangible—and, above all, in showing what they mean for those affected: hope for a life as normal as possible, stability, and a future.
In the end, one clear message remains: behind every therapy are many people—from donors to the teams in development and production.
